Peritoneal dialysis in diabetic patients.
Bertoli
M
M
Department of Medical and Surgical Sciences, Division of Nephrology, University of Padova and Azienda Ospedaliera di Padova, Italy. bertolim@tin.it
Bonfante
L
L
Gambaro
G
G
Cara
M
M
Virgilio
B
B
D'Angelo
A
A
D001682:Biological Availability; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy; D003928:Diabetic Nephropathies / Q000097:blood / Q000150:complications / Q000628:therapy*; D015314:Dialysis Solutions / Q000009:adverse effects; D005947:Glucose / Q000009:adverse effects; D017127:Glycation End Products, Advanced / Q000097:blood; D006801:Humans; D006973:Hypertension / Q000209:etiology / Q000628:therapy; D007274:Injections, Intraperitoneal; D007328:Insulin / Q000008:administration & dosage / Q000493:pharmacokinetics; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000628:therapy*; D010530:Peritoneal Dialysis / Q000009:adverse effects / Q000379:methods / Q000706:statistics & numerical data; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000706:statistics & numerical data; D010538:Peritonitis / Q000209:etiology; D006435:Renal Dialysis / Q000706:statistics & numerical data; D012306:Risk; D016019:Survival Analysis; D015996:Survival Rate; D016896:Treatment Outcome; D014511:Uremia / Q000097:blood / Q000209:etiology / Q000628:therapy; D014652:Vascular Diseases / Q000209:etiology / Q000628:therapy
D015314:Dialysis Solutions; D017127:Glycation End Products, Advanced; D007328:Insulin; D005947:Glucose